Home > 暂无记录 暂无记录 行业新闻

行业新闻


  • FT-207 EY2234

    FT-207 (NSC 148958) is a substance being used in the treatment of some types of cancer.

    More
  • Felbamate EY2237

    Felbamate (Felbatol,FBM) is an anticonvulsant drug used in the treatment of epilepsy.

    More
  • Clofarabine EY2225

    Clofarabine is a potent HIV-1 inhibitor in both activated CD4+ T cells and macrophages. Clofarabine inhibits the enzymatic activities of ribonucleotide reductase (IC50 = 65 nM) and DNA polymerase

    More
  • Masitinib EY2221

    Masitinib, a novel phenylaminothiazole-type derivative, is an inhibitor of the class III receptor tyrosine kinase stem-cell growth factor receptor (c-Kit) with IC50 of 200 nM, platelet-derived growth factor receptor α and β and the non-receptor tyrosine kinase Lyn(PDGFRα/β with IC50 of 540 nM/800 nM).

    More
  • Quisinostat EY2222

    Quisinostat (JNJ-26481585) is a novel second-generation HDACi inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM, modest potent to HDACs 2, 4, 10, and 11; greater than 30-fold selectivity against HDACs 3, 5, 8, and 9 and lowest potency to HDACs 6 and 7. , in NSCLC cells. In vitro, quisinostat has shown anti-proliferative activity against NSCLC cell lines. quisinostat extremely changed protein acetylation patterns of A549 cells and inhibited epithelial-mesenchymal transition (EMT) process.

    More
  • Current page37, Total Pages314, Total Record1566 First Prev 3536373839 Next Last Goto